NearWave Analysis: $1M Raised
What is NearWave?
NearWave develops non-invasive devices using frequency domain near infrared spectroscopy to assess vital biomarkers like tissue oxygen saturation and hemoglobin concentrations.
Employees
3
Founded
2022
Revenue
$0-968K
Product Features & Capabilities
- NearWave Scanner, non-invasive device, frequency domain near infrared spectroscopy (fdNIRS), measures tissue oxygenation, assesses StO2, HHb, HbO2, and THb, applicable in sports medicine, weight loss, cardiovascular health assessment.
How much NearWave raised
s for NearWave: - $1.2 million
Not specifiedLead Investor: Not specified
Who are the founders of NearWave
RS
Market Focus
NearWave primarily focuses on the healthcare industry, specifically in the field of medical technology. They develop non-invasive devices that utilize frequency domain near infrared spectroscopy (fdNIRS) to assess vital biomarkers, such as tissue oxygen saturation and hemoglobin concentrations.
Investors
- Y Combinator
- CANCER FUND
- Tampa Bay Wave
- Flywheel Fund
- IrishAngels
- VentureSouq
Competitors Overview
The main competitors of NearWave in the non-invasive medical device market, particularly in the field of frequency domain near infrared spectroscopy (fdNIRS), include:
- Artinis Medical Systems:
- Overview: Artinis specializes in (f)NIRS devices and has been providing solutions for ove
See something that needs updating? Suggest edits to this profile.